Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With Lexapro
Phase 4
Completed
- Conditions
- Insomnia
- Registration Number
- NCT00296179
- Lead Sponsor
- Sanofi
- Brief Summary
To demonstrate overall improvement of insomnia in subjects treated with zolpidem tartrate extended-release (Ambien CR) and escitalopram (Lexapro) vs. subjects treated with placebo and escitalopram at 2 months.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 372
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Efficacy: Patient-reported TST
- Secondary Outcome Measures
Name Time Method Difference in relapse rates in patients receiving placebo and patients receiving zolpidem MR during 4 month follow-up period